Patent Law Weblog
recent posts
- Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. (2026)
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
about
Month: April 2008
-
Practising Law Institute (PLI) will be holding a conference entitled: "Advanced Patent Licensing 2008: What You Need to Know Before Licensing Your Patent" on May 28, 2008 in New York, NY and on June 11, 2008 in San Francisco, CA. The conference will offer presentations on the following topics: I. What’s Hot in Patent Licensing…
-
Practising Law Institute (PLI) will be holding a conference entitled: "Fundamentals of Patent Prosecution 2008: A Boot Camp for Claim Drafting & Amendment Writing" on June 18-20, 2008 in New York, NY and on July 9-11, 2008 in San Francisco, CA. The three-day program will consist of morning lectures followed by small clinic sessions in…
-
Practising Law Institute (PLI) will be holding a conference entitled: "Prior Art & Obviousness 2008: The PTO and CAFC Perspective on Patent Law Sections 102 & 103" on July 1, 2008 in New York, NY. The conference will offer presentations on the following topics: I. Overview of Sections 102 and 103 A. Section 102 and…
-
By Donald Zuhn — Yesterday, StemCells, Inc. announced that the U.S. Patent and Trademark Office has issued U.S. Patent No. 7,361,505, which is directed to multipotent neural stem cell compositions. While the ‘505 patent is assigned to Neurospheres Holdings Ltd., StemCells notes that it has exclusively licensed the patent. As we reported earlier…
-
By Donald Zuhn — Last August, the U.S. Patent and Trademark Office published a notice of proposed rule making entitled "Examination of Patent Applications That Include Claims Containing Alternative Language" (sometimes referred to as the Markush rules). The Office’s proposed rule making would require each claim in an application to be limited to…
-
By Donald Zuhn — Last week, StemCells, Inc. announced that the U.S. Patent and Trademark Office had issued Notices of Intent to Issue Ex Parte Reexamination Certificates with respect to the Palo Alto-based biotech company’s U.S. Patent Nos. 5,851,832 and 6,497,872. The ‘832 patent, entitled "In vitro growth and proliferation of multipotent neural…
-
By Donald Zuhn — On April 1st, we reported on a press release issued by the Biotechnology Industry Organization (BIO) concerning a report from the Coalition for Patent Fairness that the Senate patent reform bill (S. 1145) would soon be coming to a vote. BIO disputed this report, stating that the organization was…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. Sepracor Inc. et al. v. Synthon Pharmaceuticals, Inc. et al.5:08-cv-00179; filed April 11, 2008 in the Eastern District of North Carolina Sepracor…
-
April 25, 2008 – Patent Claim Construction (Law Seminars International) – Atlanta, GA April 30, 2008 – Public PAIR and Data-Mining Requests Webcast (U.S. Patent and Trademark Office) April 30-May 1, 2008 – Pharma/Biotech Collaborative Agreements (American Conference Institute) – San Francisco, CA May 15, 2008 – The Federal Circuit: A National Court of Appeals:…
-
By Christopher P. Singer — In an April 14, 2008 pre-O.G. notice the U.S. Patent and Trademark Office made a request for voluntary submission of electronic Complex Work Unit (CWU) files as part of its Pilot Program. This program became effective on April 14, 2008 and is intended to alleviate the publication burden…
Patent Docs 